Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease pneumonia
Phenotype C0024117|chronic obstructive pulmonary disease
Sentences 36
PubMedID- 20176867 Use of inhaled budesonide for 1 year does not increase risk of pneumonia in patients with chronic obstructive pulmonary disease.
PubMedID- 23396513 Computer-aided diagnosis of pneumonia in patients with chronic obstructive pulmonary disease.
PubMedID- 23605250 Nontypeable haemophilus influenzae (nthi) is an opportunistic pathogen and a common cause of otitis media in children, chronic bronchitis, and pneumonia in patients with chronic obstructive pulmonary disease.
PubMedID- 23039314 Background and objective: recent studies have raised concerns about the link between use of inhaled corticosteroids (ics) and risk of pneumonia in patients with chronic obstructive pulmonary disease.
PubMedID- 26496284 Inhaled corticosteroids increase the risk of pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study.
PubMedID- 25409118 Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease.
PubMedID- 19926996 Purpose of review: the aim was to determine the effects of long-term inhaled corticosteroid use on pneumonia in patients with chronic obstructive pulmonary disease (copd) via systematic searches of medline, embase, isi, regulatory documents and manufacturers' trial registries.
PubMedID- 24636725 Mortality in community-acquired pneumonia associated with chronic obstructive pulmonary disease: some reflections about this overly complex issue.
PubMedID- 26113207 Introduction: inhaled corticosteroids (ics) are known to increase the risk of pneumonia in patients with chronic obstructive pulmonary disease.
PubMedID- 25166349 Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
PubMedID- 22569097 For example, if a medical examiner reports pneumonia with chronic obstructive pulmonary disease both conditions will be shown in entity axis code data.
PubMedID- 24709704 For example, another fpr2/alx ligand, saa generates potent anti-apoptosis signals that can be overridden by lxa4 [38], whereas excessive production of saa was found to mediate exacerbation of glucocorticoid-refractory lung inflammation in patients with chronic obstructive pulmonary disease by overwhelming lxa4-generated anti-inflammatory signaling [107].
PubMedID- 24130228 Inhaled corticosteroids are known to increase the risk of developing pneumonia in patients with chronic obstructive pulmonary disease (copd), but it is unclear whether this risk varies for different agents, particularly fluticasone and budesonide.
PubMedID- 23508943 A recent study reported that serum amyloid a acting through the formyl-peptide receptor 2/lipoxin receptor (fpr2/alx) can overwhelm anti-inflammatory signaling by lxa4 to mediate exacerbation of glucocorticoid refractory lung inflammation in patients with chronic obstructive pulmonary disease (bozinovski et al., 2012).
PubMedID- 25263974 Cm extract may have an inhibitory effect on pulmonary inflammation related with chronic obstructive pulmonary disease.
PubMedID- 26491501 Proton pump inhibitors did not increase risk of pneumonia in patients with chronic obstructive pulmonary disease.
PubMedID- 23957707 Exclusion criteria were (i) recent hospitalization (<2 weeks) or residence in long-term care facilities, (ii) known bronchial obstruction or a history of post-obstructive pneumonia (with exception of chronic obstructive pulmonary disease), (iii) primary lung cancer or another malignancy metastatic to the lungs, (iv) aids, known or suspected pneumocystis jirovecii pneumonia, and (v) known or suspected active tuberculosis.
PubMedID- 25421860 Community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
PubMedID- 25987742 Inhaled corticosteroids (ics) increase community-acquired pneumonia (cap) incidence in patients with chronic obstructive pulmonary disease (copd) by unknown mechanisms.
PubMedID- 23445751 Recently it has been suggested that there is a causal association between the use of inhaled corticosteroids (icss) and the risk of developing pneumonia in patients with chronic obstructive pulmonary disease (copd).
PubMedID- 20016134 Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease.
PubMedID- 25293857 Clinical studies have suggested that inhaled corticosteroid (ics) increases the frequency of pneumonia in patients with chronic obstructive pulmonary disease (copd).
PubMedID- 25729735 Here, we report a case of c. lapagei pneumonia in a patient with chronic obstructive pulmonary disease (copd).
PubMedID- 19850707 Over the last 20-30 years, this bacterium has emerged as a genuine pathogen, and is now considered an important cause of otitis media in children and an aetiological agent in pneumonia in adults with chronic obstructive pulmonary disease.
PubMedID- 21962211 Background: an increased incidence of pneumonia in patients with chronic obstructive pulmonary disease (copd) under inhaled corticosteroid (ics) therapy was noticed in previous studies.
PubMedID- 19843708 chronic obstructive pulmonary disease (copd) is associated with pulmonary inflammation with increased numbers of macrophages located in the parenchyma.
PubMedID- 25366026 Daptomycin-induced pneumonitis in a patient with chronic obstructive pulmonary disease (copd).
PubMedID- 24075301 Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality.
PubMedID- 25776950 A new report investigates how lung inflammation in patients with chronic obstructive pulmonary disease affects protein citrullination, providing an additional piece of information on the potential link between airway inflammation and ra.
PubMedID- 24739467 The non-typed forms of h. influenzae (nthi) are generally associated to moderate diseases of the upper respiratory tract in children and pneumonia in adults with chronic obstructive pulmonary disease (copd) or cystic fibrosis [11].
PubMedID- 24244086 Several studies have shown that the risk of pneumonia is increased in patients with chronic obstructive pulmonary disease (copd) who are receiving chronic inhaled corticosteroids (ics).
PubMedID- 22633726 In this case, a 57-year-old white female admitted for a chronic obstructive pulmonary disease exacerbation with pneumonitis and hypoxic respiratory failure experienced contrast extravasation during a computed tomographic scan of her chest.
PubMedID- 24669074 Impact of ventilator associated pneumonia on outcome in patients with chronic obstructive pulmonary disease exacerbation.
PubMedID- 21622588 Cigarette smoke (cs), the primary risk factor of chronic obstructive pulmonary disease (copd), leads to pulmonary inflammation through interleukin-1 receptor (il-1r)i signalling, as determined using copd mouse models.
PubMedID- 24920884 Purpose: complications of pneumonia development in patients with chronic obstructive pulmonary disease (copd) receiving inhaled corticosteroid (ics) therapy have been documented.
PubMedID- 22551902 Treatments were well tolerated with only one case of grade 2 fatigue, one case of grade 2 dermatitis, three cases of rib fracture (maximum grade 2), and one case of grade 3 pneumonitis in a patient with severe chronic obstructive pulmonary disease.

Page: 1